Pierfrancesco Tassone

Pierfrancesco Tassone

UNVERIFIED PROFILE

Are you Pierfrancesco Tassone?   Register this Author

Register author
Pierfrancesco Tassone

Pierfrancesco Tassone

Publications by authors named "Pierfrancesco Tassone"

Are you Pierfrancesco Tassone?   Register this Author

100Publications

2829Reads

6Profile Views

An Anti-BCMA RNA Aptamer for miRNA Intracellular Delivery.

Mol Ther Nucleic Acids 2019 Dec 28;18:981-990. Epub 2019 Oct 28.

IEOS - Istituto per l'endocrinologia e l'oncologia "Gaetano Salvatore," CNR, Naples, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.omtn.2019.10.021DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889555PMC
December 2019

Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides.

Medchemcomm 2019 Jan 5;10(1):116-119. Epub 2018 Dec 5.

Dipartimento di Scienze della Salute , Università Magna Græcia , Viale Europa, Germaneto , Catanzaro , 88100 , Italy . Email:

View Article

Download full-text PDF

Source
http://xlink.rsc.org/?DOI=C8MD00503F
Publisher Site
http://dx.doi.org/10.1039/c8md00503fDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350762PMC
January 2019

The Era of PARP inhibitors in ovarian cancer: "Class Action" or not? A systematic review and meta-analysis.

Crit Rev Oncol Hematol 2018 Nov 3;131:83-89. Epub 2018 Sep 3.

Medical Oncology, Department of Experimental and Clinical Medicine, Magna Græcia University and Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10408428183025
Publisher Site
http://dx.doi.org/10.1016/j.critrevonc.2018.08.011DOI Listing
November 2018

The potential role of miRNAs in multiple myeloma therapy.

Expert Rev Hematol 2018 10 12;11(10):793-803. Epub 2018 Sep 12.

a Department of Experimental and Clinical Medicine , Magna Græcia University, Campus Salvatore Venuta , Catanzaro , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17474086.2018.1517041DOI Listing
October 2018

Immunomodulatory Activity of MicroRNAs: Potential Implications for Multiple Myeloma Treatment.

Curr Cancer Drug Targets 2017 ;17(9):819-838

Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro. Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1568009617666170330154756DOI Listing
June 2018

The best strategy for RAS wild-type metastatic colorectal cancer patients in first-line treatment: A classic and Bayesian meta-analysis.

Crit Rev Oncol Hematol 2018 May 9;125:69-77. Epub 2018 Mar 9.

Medical Oncology, Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.critrevonc.2018.03.003DOI Listing
May 2018

MALAT1: a druggable long non-coding RNA for targeted anti-cancer approaches.

J Hematol Oncol 2018 05 8;11(1):63. Epub 2018 May 8.

Department of Experimental and Clinical Medicine, Magna Graecia University, Viale Europa, 88100, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13045-018-0606-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941496PMC
May 2018

Mouse models of multiple myeloma: technologic platforms and perspectives.

Oncotarget 2018 Apr 13;9(28):20119-20133. Epub 2018 Apr 13.

Department of Experimental and Clinical Medicine, "Magna Graecia" University of Catanzaro, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.24614DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929451PMC
April 2018

Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma.

Oncotarget 2017 Dec 20;8(63):106527-106537. Epub 2017 Nov 20.

Department of Experimental and Clinical Medicine, Magna Graecia University of Catanzaro, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22507DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739753PMC
December 2017

Circulating biomarkers in osteosarcoma: new translational tools for diagnosis and treatment.

Oncotarget 2017 Nov 3;8(59):100831-100851. Epub 2017 Aug 3.

Rizzoli Orthopedic Institute, Innovative Technology Platforms for Tissue Engineering, Theranostic and Oncology, Palermo, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.19852DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725068PMC
November 2017

Non Coding RNAs: A New Avenue for the Self-Tailoring of Blood Cancer Treatment.

Curr Drug Targets 2017 ;18(1):35-55

Department of Biochemistry, Biophysics and General Pathology, Second Naples University, Via S.M. Costantinopoli, 16, 80138, Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/1389450117666160606104208DOI Listing
September 2017

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients.

Blood Adv 2017 Feb 27;1(7):455-466. Epub 2017 Feb 27.

Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy; and.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/bloodadvances.2016003905DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738982PMC
February 2017

Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.

Expert Opin Ther Targets 2017 Jan;21(1):91-101

b Department of Biology, Ecology and Earth Sciences , University of Calabria , Rende , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2016.1266339DOI Listing
January 2017

Functional Analysis of microRNA in Multiple Myeloma.

Methods Mol Biol 2016 ;1375:181-94

Department of Experimental and Clinical Medicine, T. Campanella Cancer Center, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Viale Europa, 88100, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/7651_2015_250DOI Listing
December 2016

Systematic review and meta-analysis on targeted therapy in advanced pancreatic cancer.

Pancreatology 2016 Mar-Apr;16(2):249-58. Epub 2016 Jan 20.

Medical Oncology and Translational Medical Oncology Units, Department of Experimental and Clinical Medicine, Magna Graecia University, AOU Materdomini Catanzaro, CampusSalvatore Venuta, Catanzaro 88100, Italy. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pan.2016.01.003DOI Listing
December 2016

MicroRNAs: Novel Crossroads between Myeloma Cells and the Bone Marrow Microenvironment.

Biomed Res Int 2016 4;2016:6504593. Epub 2016 Jan 4.

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2016/6504593DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736225PMC
November 2016

Immunotherapy of colorectal cancer: new perspectives after a long path.

Immunotherapy 2016 11;8(11):1281-1292

Medical Oncology Unit & Medical Oncology Unit, AUO 'Materdomini', Magna Grecia University, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/imt-2016-0089DOI Listing
November 2016

Mir-221/222 are promising targets for innovative anticancer therapy.

Expert Opin Ther Targets 2016 Sep 21;20(9):1099-108. Epub 2016 Mar 21.

a Department of Experimental and Clinical Medicine , Magna Graecia University, Salvatore Venuta University Campus , Catanzaro , Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14728222.2016.1164693DOI Listing
September 2016

OSAnalyzer: A Bioinformatics Tool for the Analysis of Gene Polymorphisms Enriched with Clinical Outcomes.

Microarrays (Basel) 2016 Sep 23;5(4). Epub 2016 Sep 23.

Department of Medical and Surgical Science, University Magna Graecia of Catanzaro, Catanzaro 88100, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/microarrays5040024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5197943PMC
September 2016

DMET™ (Drug Metabolism Enzymes and Transporters): a pharmacogenomic platform for precision medicine.

Oncotarget 2016 08;7(33):54028-54050

Department of Experimental and Clinical Medicine, Medical Oncology Unit, Mater Domini Hospital, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.9927DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288240PMC
August 2016

Therapeutic Targeting of miR-29b/HDAC4 Epigenetic Loop in Multiple Myeloma.

Mol Cancer Ther 2016 06 18;15(6):1364-75. Epub 2016 May 18.

Department of Experimental and Clinical Medicine, Magna Graecia University and Translational Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-15-0985DOI Listing
June 2016

Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates.

Mol Ther Nucleic Acids 2016 Jun 21;5(6). Epub 2016 Jun 21.

Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mtna.2016.36DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5022129PMC
June 2016

mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials.

Oncotarget 2016 May;7(19):27055-66

Department of Experimental and Clinical Medicine, Medical Oncology, Magna Graecia University, Viale Europa, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053632PMC
http://dx.doi.org/10.18632/oncotarget.7446DOI Listing
May 2016

A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells.

Clin Cancer Res 2016 Mar 2;22(5):1222-33. Epub 2015 Nov 2.

Department of Experimental and Clinical Medicine, Magna Græcia University, Campus Salvatore Venuta, Catanzaro, Italy. Center for Biotechnology, Sbarro Institute for Cancer Research and Molecular Medicine, College of Science and Technology, Temple University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-15-0489DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775414PMC
March 2016

Analysis of miRNA, mRNA, and TF interactions through network-based methods.

EURASIP J Bioinform Syst Biol 2015 Dec 4;2015. Epub 2015 Jun 4.

Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13637-015-0023-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270379PMC
December 2015

Delivery of miR-34a by chitosan/PLGA nanoplexes for the anticancer treatment of multiple myeloma.

Sci Rep 2015 Dec 1;5:17579. Epub 2015 Dec 1.

Department of Experimental and Clinical Medicine, University "Magna Græcia" of Catanzaro, Campus Universitario "S. Venuta", Viale S. Venuta, Germaneto, I-88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep17579DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665167PMC
December 2015

MicroRNAs in multiple myeloma and related bone disease.

Ann Transl Med 2015 Dec;3(21):334

1 Department of Experimental and Clinical Medicine, Magna Graecia University, Campus Salvatore Venuta, Catanzaro, Italy ; 2 Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2305-5839.2015.12.13DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690997PMC
December 2015

miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.

Oncotarget 2015 May;6(15):12837-61

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536984PMC
http://dx.doi.org/10.18632/oncotarget.3805DOI Listing
May 2015

A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells.

J Cell Physiol 2014 Dec;229(12):2106-16

Department of Experimental and Clinical Medicine, Magna Graecia University, Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcp.24669DOI Listing
December 2014

Physicochemical features and transfection properties of chitosan/poloxamer 188/poly(D,L-lactide-co-glycolide) nanoplexes.

Int J Nanomedicine 2014 15;9:2359-72. Epub 2014 May 15.

Department of Health Sciences, University Magna Græcia of Catanzaro, Catanzaro, Italy ; Interregional Research Center for Food Safety and Health, University of Catanzaro "Magna Græcia", Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/IJN.S58362DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035313PMC
December 2014

Myeloid-derived suppressor cells in multiple myeloma: pre-clinical research and translational opportunities.

Front Oncol 2014 8;4:348. Epub 2014 Dec 8.

Department of Experimental and Clinical Medicine, "Magna Graecia" University and Medical Oncology Unit, T. Campanella Cancer Center, "Salvatore Venuta" University Campus , Catanzaro , Italy ; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University , Philadelphia, PA , USA.

View Article

Download full-text PDF

Source
http://journal.frontiersin.org/article/10.3389/fonc.2014.003
Publisher Site
http://dx.doi.org/10.3389/fonc.2014.00348DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258997PMC
December 2014

In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.

PLoS One 2014 21;9(2):e89659. Epub 2014 Feb 21.

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, Salvatore Venuta University Campus, Catanzaro, Italy ; T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy ; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0089659PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931823PMC
October 2014

In vivo activity of miR-34a mimics delivered by stable nucleic acid lipid particles (SNALPs) against multiple myeloma.

PLoS One 2014 27;9(2):e90005. Epub 2014 Feb 27.

Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples, Italy ; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0090005PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3937395PMC
October 2014

Mir-34: a new weapon against cancer?

Mol Ther Nucleic Acids 2014 Sep 23;3:e194. Epub 2014 Sep 23.

1] Department of Experimental and Clinical Medicine, Magna Graecia University and Medical OncologyUnit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy [2] Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mtna.2014.47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4222652PMC
September 2014

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials.

Cancer Biol Ther 2014 Jun 21;15(6):707-20. Epub 2014 Mar 21.

Medical Oncology Unit; Department of Experimental and Clinical Medicine; Magna Græcia University and T. Campanella Cancer Center; Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/abs/10.4161/cbt.28557
Publisher Site
http://dx.doi.org/10.4161/cbt.28557DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4049787PMC
June 2014

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial.

J Immunother 2014 Jan;37(1):26-35

*Radiotherapy Unit §Medical Oncology Unit, Department of Oncology, Microbiology Section ∥Department of Biotechnology ¶Rheumatology Unit, Department of Medicine #Pharmacy Unit, Siena University Hospital "Santa Maria alle Scotte", Istituto Toscano Tumory, Siena †Medical Oncology Unit ‡Department of Legal, Historical, Economic and Social Sciences-DSGSES, Magna Graecia University of Catanzaro ††Translational Medical Oncology Unit, "Magna Graecia" University and "Tommaso Campanella" Cancer Center, Campus "Salvatore Venuta," Catanzaro **Department of Biochemistry, Biophysics and General Pathology, Second University of Naples, Naples ‡‡Chemotherapy Unit, Department of Oncology, Florence University School of Medicine, Florence §§Medical Oncology Unit, Department of Oncology, Cagliari University School of Medicine, Cagliari ∥∥Medical Oncology Unit, Centro Oncologico Romagnolo, Forlì, Italy.

View Article

Download full-text PDF

Source
http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:land
Publisher Site
http://dx.doi.org/10.1097/CJI.0000000000000004DOI Listing
January 2014

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells.

Cell Cycle 2013 Dec 25;12(23):3650-62. Epub 2013 Sep 25.

Department of Experimental and Clinical Medicine; Magna Graecia University and Medical Oncology Unit; T. Campanella Cancer Center; Salvatore Venuta University Campus; Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cc.26585DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903716PMC
December 2013

Clinical monoclonal B lymphocytosis versus Rai 0 chronic lymphocytic leukemia: A comparison of cellular, cytogenetic, molecular, and clinical features.

Clin Cancer Res 2013 Nov 13;19(21):5890-900. Epub 2013 Sep 13.

Authors' Affiliations: Department of Onco-Hematology, A.O. of Cosenza, Cosenza; Department of Clinical Sciences and Community Health, University of Milano and Hematology 1 CTMO, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano; SS Molecular Diagnostics, Scientific Direction, and Direzione Scientifica, IRCCS, San Martino IST, Genoa; Department of Experimental and Diagnostic Medicine, University of Ferrara, Ferrara; Division of Hematology, A.O. Arcispedale Santa Maria Nuova-IRCCS, Reggio Emilia; Division of Hematology, University of Messina, Messina; Department of Oncology and Hematology, Pugliese-Ciaccio Hospital; University of Magna Graecia and Cancer Center, Catanzaro; Division of Hematology, Department of Biomedical Sciences, University of Catania and Ferrarotto Hospital, Catania; and Division of Hematology, Department of Clinical and Experimental Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0622DOI Listing
November 2013

From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.

Curr Drug Targets 2013 Sep;14(10):1144-9

Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/13894501113149990186DOI Listing
September 2013

Molecular profiling of multiple myeloma: from gene expression analysis to next-generation sequencing.

Expert Opin Biol Ther 2013 Jun 24;13 Suppl 1:S55-68. Epub 2013 Apr 24.

University of Milan, Department of Clinical Sciences and Community Health, F. Sforza, 35 - 20122 Milan, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.793305DOI Listing
June 2013

Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma.

Expert Opin Biol Ther 2013 Jun 22;13 Suppl 1:S125-37. Epub 2013 May 22.

Magna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.796356DOI Listing
June 2013

Immunologic microenvironment and personalized treatment in multiple myeloma.

Expert Opin Biol Ther 2013 Jun 22;13 Suppl 1:S83-93. Epub 2013 May 22.

Magna Graecia University and T. Campanella Cancer Center, Department of Experimental and Clinical Medicine, Medical Oncology Unit, Viale Europa, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.799130DOI Listing
June 2013

Nanoparticle albumin bound Paclitaxel in the treatment of human cancer: nanodelivery reaches prime-time?

J Drug Deliv 2013 2;2013:905091. Epub 2013 May 2.

Medical Oncology Unit, Department of Experimental and Clinical Medicine, University "Magna Graecia" of Catanzaro and "Tommaso Campanella" Cancer Center, Campus Salvatore Venuta, Viale Europa, 88100 Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2013/905091DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659516PMC
June 2013

Emerging pathways as individualized therapeutic target of multiple myeloma.

Expert Opin Biol Ther 2013 Jun 6;13 Suppl 1:S95-109. Epub 2013 Jun 6.

Second University of Naples, Department of Biochemistry, Biophysics and General Pathology, Via S.M. Costantinopoli, 16, 80138 Naples, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14712598.2013.807338DOI Listing
June 2013

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth.

Clin Cancer Res 2013 Apr 27;19(8):2096-106. Epub 2013 Feb 27.

Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Graecia University and T. Campanella Cancer Center, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-12-3325DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147955PMC
April 2013

A retrospective analysis of pegylated liposomal doxorubicin in ovarian cancer: do we still need it?

J Ovarian Res 2013 Feb 6;6(1):10. Epub 2013 Feb 6.

Medical Oncology Unit, Department of Experimental and Clinical Medicine, Magna Græcia University and Tommaso Campanella Cancer Center, Campus Salvatore Venuta, Catanzaro, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1757-2215-6-10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599392PMC
February 2013